EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Treg Cell Therapeutic Strategies for Breast Cancer: Holistic to Local Aspects

Hanwen Zhang iD, Oliver Felthaus iD, Andreas Eigenberger, Silvan Klein iD, Lukas Prantl iD

Cells · 11.09.2024 · 13 (18) · 1526

DOI: 10.3390/cells13181526 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 11.09.2024. Verfasst von Hanwen Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Plastic, Hand and Reconstructive Surgery, University Hospital Regensburg, Franz-Josef-Strauss Allee 11, 93053 Regensburg, Germany. Hauptthemen laut MEDLINE: Breast Neoplasms, T-Lymphocytes, Regulatory, Tumor Microenvironment. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 296 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Regulatory T cells (Tregs) play a key role in maintaining immune homeostasis and preventing autoimmunity through their immunosuppressive function. There have been numerous reports confirming that high levels of Tregs in the tumor microenvironment (TME) are associated with a poor prognosis, highlighting their role in promoting an immunosuppressive environment. In breast cancer (BC), Tregs interact with cancer cells, ultimately leading to the suppression of immune surveillance and promoting tumor progression. This review discusses the dual role of Tregs in breast cancer, and explores the controversies and therapeutic potential associated with targeting these cells. Researchers are investigating various strategies to deplete or inhibit Tregs, such as immune checkpoint inhibitors, cytokine antagonists, and metabolic inhibition. However, the heterogeneity of Tregs and the variable precision of treatments pose significant challenges. Understanding the functional diversity of Tregs and the latest advances in targeted therapies is critical for the development of effective therapies. This review highlights the latest approaches to Tregs for BC treatment that both attenuate Treg-mediated immunosuppression in tumors and maintain immune tolerance, and advocates precise combination therapy strategies to optimize breast cancer outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsT-Lymphocytes, RegulatoryTumor MicroenvironmentHumansFemaleAnimalsImmunotherapy

Stichwörter der Autor:innen

breast cancerregulatory T cellstreatment

Autor:innen und Institutionen

  • Department of Plastic, Hand and Reconstructive Surgery, University Hospital Regensburg, Franz-Josef-Strauss Allee 11, 93053 Regensburg, Germany.

ORCID-Profile: Hanwen Zhang, Oliver Felthaus, Silvan Klein, Lukas Prantl

Zitieren

APA

Zhang, H., Felthaus, O., Eigenberger, A., Klein, S., & Prantl, L. (2024). Treg Cell Therapeutic Strategies for Breast Cancer: Holistic to Local Aspects. Cells, 13(18), 1526. https://doi.org/10.3390/cells13181526

Vancouver

Zhang H, Felthaus O, Eigenberger A, Klein S, Prantl L. Treg Cell Therapeutic Strategies for Breast Cancer: Holistic to Local Aspects. Cells. 2024;13(18):1526. doi:10.3390/cells13181526

BibTeX
@article{Zhang2024,
  author = {Zhang, Hanwen and Felthaus, Oliver and Eigenberger, Andreas and Klein, Silvan and Prantl, Lukas},
  title = {Treg Cell Therapeutic Strategies for Breast Cancer: Holistic to Local Aspects},
  journal = {Cells},
  year = {2024},
  volume = {13},
  number = {18},
  pages = {1526},
  doi = {10.3390/cells13181526}
}
Kostenlos starten →